FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.00 $ -0.99 (-19.84 %)    

Monday, 01-Jul-2024 15:59:38 EDT
QQQ $ 480.83 $ 0.94 (0.2 %)
DIA $ 390.84 $ 0.00 (0 %)
SPY $ 543.97 $ -1.37 (-0.25 %)
TLT $ 90.67 $ 0.00 (0 %)
GLD $ 215.25 $ -0.02 (-0.01 %)
$ 4
$ 4.82
$ 3.97 x 145
$ 0.00 x 0
$ 3.98 - $ 5.12
$ 3.90 - $ 55.00
313,496
na
124.54M
$ -3.47
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...